Evidence map›Paper›PMID 40705114›Full record

ArticleCurrent microbiology2025

Purification and Characterization of Antimicrobial Peptide from an Epilithic Bacterium Streptomyces sp. AL50 with Activity Against Biofilm Forming Coagulase-Negative Staphylococci.

Santa Ram Joshi, Kaushik Bhattacharjee

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Santa Ram JoshiMicrobiology Laboratory, Department of Biotechnology & Bioinformatics, North-Eastern Hill University, Shillong, 793022, India.
Kaushik BhattacharjeeMicrobiology Laboratory, Department of Biotechnology & Bioinformatics, North-Eastern Hill University, Shillong, 793022, India. kaushik_asm@yahoo.com.ORCID http://orcid.org/0000-0002-2866-2239

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial peptide (AMP) is increasingly recognized as a promising new avenue in addressing the challenge of antibiotic resistance, offering a notable alternative to traditional antibiotic molecules. The current research focuses on extracting and characterizing AMP named as AMP1 from epilithic bacterial isolate Streptomyces sp. AL50, an area that has so far remained underexplored. The AMP1 was purified by ammonium sulfate precipitation, dialysis, and sephadex G-100 column chromatography. Subsequent analysis using Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed major band with molecular mass of approximately 10.83 kDa. The peptide demonstrated potent activity against Staphylococcus epidermis MTCC3615, with MIC value of 4 μg/mL. Remarkably, the peptide retained its activity up to 70 °C temperature and within a pH range of 6.0-8.0. However, its activity was abolished by proteinase K, trypsin, and papain, while pepsin, lipase, and α-amylase had no effect. Furthermore, AMP1 displayed notable capabilities in inhibiting and eradicating biofilms. These results indicate that AMP1 hold significant potential as antibiotic candidates for treating multidrug-resistant bacterial infections.

Indexed as

Anti-Bacterial AgentsAntimicrobial PeptidesBiofilmsStaphylococcusStreptomycesCoagulaseHydrogen-Ion ConcentrationMicrobial Sensitivity TestsMolecular WeightAnti-Bacterial AgentsAntimicrobial PeptidesCoagulase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.